Juniper Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsJuniper Pharmaceuticals

Juniper Pharmaceuticals(JNP)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Antithrombin iii

primary myelofibrosis

,

healthy volunteers/patients

,

pancreatic neoplasms

,

uterine cervical neoplasms

,

autistic disorder

,

autism spectrum disorder

,

pervasive child development disorders

,

,

central nervous system neoplasms

,

nervous system neoplasms

,

non-small-cell lung carcinoma

,

breast neoplasms

,

,

,

,

colorectal neoplasms

,

alzheimer disease

,

ovarian neoplasms

,

b-cell lymphoma

,

small cell lung carcinoma

,

,

,

,

stomach neoplasms

,

,

ulcerative colitis

,

,

,

macular degeneration

,

,

hepatocellular carcinoma

,

renal cell carcinoma

,

triple negative breast neoplasms

,

ovarian epithelial carcinoma

,

large b-cell lymphoma diffuse

,

follicular lymphoma

,

lupus nephritis

,

,

,

non-hodgkin lymphoma

,

wet macular degeneration

,

,

,

liver neoplasms

,

urinary bladder neoplasms

,

peritoneal neoplasms

,

colonic neoplasms

,

head and neck neoplasms

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

paroxysmal hemoglobinuria

,

,

,

,

squamous cell carcinoma

,

fallopian tube neoplasms

,

transitional cell carcinoma

,

neoplasm metastasis

,

kidney diseases

,

multiple sclerosis

,

chronic progressive multiple sclerosis

,

,

retinal vein occlusion

,

,

,

hemolytic anemia

,

hemolytic-uremic syndrome

,

atypical hemolytic uremic syndrome

,

,

systemic lupus erythematosus

,

nephrotic syndrome

,

,

lipoid nephrosis

,

,

ischemic stroke

,

,

,

esophageal squamous cell carcinoma

,

esophageal neoplasms

,

squamous cell carcinoma of head and neck

,

human influenza

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

urologic neoplasms

,

thyroid neoplasms

,

neuroendocrine carcinoma

,

papillary thyroid cancer

,

thyroid diseases

,

disease progression

,

,

chronic hepatitis b

,

,

chronic hepatitis

,

,

,

giant cell arteritis

,

polymyalgia rheumatica

,

membranous glomerulonephritis

,

respiratory tract diseases

,

germ cell and embryonal neoplasms

,

,

respiratory tract neoplasms

,

bronchogenic carcinoma

,

thoracic neoplasms

,

bronchial diseases

,

neoplasms by histologic type

,

neoplasms by site

,

nerve tissue neoplasms

,

ankylosing spondylitis

,

spondylarthritis

,

,

,

,

huntington disease

,

geographic atrophy

,

,

myasthenia gravis

,

muscle weakness

,

neuromyelitis optica

,

relapsing-remitting multiple sclerosis

,

guillain-barre syndrome

,

autoimmune diseases of the nervous system

,

hashimoto disease

,

,

partial epilepsies

,

rectal neoplasms

,

mucinous adenocarcinoma

,

ductal carcinoma breast

,

inflammatory breast neoplasms

,

bcr-abl positive chronic myelogenous leukemia

,

disability evaluation

,

cognition disorders

,

hemolytic anemia autoimmune

,

endometrial neoplasms

,

iga glomerulonephritis

,

non-muscle invasive bladder neoplasms

,

choroidal neovascularization

,

,

retinal neovascularization

,

pathologic neovascularization

,

,

diabetic nephropathies

,

myocardial infarction

,

hypersensitivity

,

,

,

renal tubular acidosis

,

,

,

fetal growth retardation

,

placenta diseases

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use